Health insurer Elevance beats profit estimates on lower medical costs
Adds revenue details from Carelon in paragraphs 2 and 6, analyst comment in paragraph 5
By Sriparna Roy and Puyaan Singh
July 17 (Reuters) -Elevance Health ELV.N beat Wall Street estimates for quarterly profit on Wednesday as the health insurer spent less than expected on covering themedical costs of its members.
Strength in itshealth services unit Carelon, higher premiums and membership growth in its Obamacare and commercial health plans helped results in the second quarter, partially offsetting a drop in memberships for Medicaid plans.
Unlike rivals such as UnitedHealth UNH.N and Humana HUM.N, Elevance has a lower exposure to government-backed Medicare Advantage (MA) plans for people aged 65 and older, where medical costs have been elevated as older adults seek procedures that were delayed during the pandemic.
For the second quarter, Elevance's medical loss ratio - the percentage of premiums spent on medical care - was 86.3%, slightly lower than the 86.4% reported last year and the 86.42% that analysts were expecting according to LSEG data.
The company's medical costs support a high but stable backdrop for demand for healthcare services, consistent withrival UnitedHealth's UNH.N earnings on Tuesday, said Bernstein analyst Lance Wilkes.
Carelon, under which Elevance operates its pharmacy benefit management unit, reported a nearly 10% rise in revenue to $13.3 billion, helped by demand for its medical benefit and behavioral health management services, as well as the acquisition of Paragon Healthcare in the first quarter.
Memberships for government-backed Medicaid insurance plans that help cover medical care costs for people with limited income fell 23.2% to 9.03 million, Elevance said.
A decrease in the number of people eligible for its Medicaid plans this year due to the end of pandemic-era policy has led to a shift in membership to sicker patients who need more medical care, the companysaid at an industry conference last month.
For the second quarter, it reported an adjusted profit of $10.12 per share, compared with estimates of $10.01.
Reporting by Puyaan Singh and Sriparna Roy in Bengaluru; Editing by Devika Syamnath
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
